178 related articles for article (PubMed ID: 12670921)
1. Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110delta.
Sawyer C; Sturge J; Bennett DC; O'Hare MJ; Allen WE; Bain J; Jones GE; Vanhaesebroeck B
Cancer Res; 2003 Apr; 63(7):1667-75. PubMed ID: 12670921
[TBL] [Abstract][Full Text] [Related]
2. The catalytic class I(A) PI3K isoforms play divergent roles in breast cancer cell migration.
De Laurentiis A; Pardo OE; Palamidessi A; Jackson SP; Schoenwaelder SM; Reichmann E; Scita G; Arcaro A
Cell Signal; 2011 Mar; 23(3):529-41. PubMed ID: 21056654
[TBL] [Abstract][Full Text] [Related]
3. Targeting the PI3K p110alpha isoform inhibits medulloblastoma proliferation, chemoresistance, and migration.
Guerreiro AS; Fattet S; Fischer B; Shalaby T; Jackson SP; Schoenwaelder SM; Grotzer MA; Delattre O; Arcaro A
Clin Cancer Res; 2008 Nov; 14(21):6761-9. PubMed ID: 18980969
[TBL] [Abstract][Full Text] [Related]
4. Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cells.
Boller D; Schramm A; Doepfner KT; Shalaby T; von Bueren AO; Eggert A; Grotzer MA; Arcaro A
Clin Cancer Res; 2008 Feb; 14(4):1172-81. PubMed ID: 18281552
[TBL] [Abstract][Full Text] [Related]
5. Specific role of phosphoinositide 3-kinase p110alpha in the regulation of phagocytosis and pinocytosis in macrophages.
Tamura N; Hazeki K; Okazaki N; Kametani Y; Murakami H; Takaba Y; Ishikawa Y; Nigorikawa K; Hazeki O
Biochem J; 2009 Sep; 423(1):99-108. PubMed ID: 19604150
[TBL] [Abstract][Full Text] [Related]
6. Investigating the role of class-IA PI 3-kinase isoforms in adipocyte differentiation.
Kim JE; Shepherd PR; Chaussade C
Biochem Biophys Res Commun; 2009 Feb; 379(4):830-4. PubMed ID: 19114029
[TBL] [Abstract][Full Text] [Related]
7. Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice.
Okkenhaug K; Bilancio A; Farjot G; Priddle H; Sancho S; Peskett E; Pearce W; Meek SE; Salpekar A; Waterfield MD; Smith AJ; Vanhaesebroeck B
Science; 2002 Aug; 297(5583):1031-4. PubMed ID: 12130661
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.
Billottet C; Banerjee L; Vanhaesebroeck B; Khwaja A
Cancer Res; 2009 Feb; 69(3):1027-36. PubMed ID: 19176369
[TBL] [Abstract][Full Text] [Related]
9. A selective inhibitor of the p110delta isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16.
Billottet C; Grandage VL; Gale RE; Quattropani A; Rommel C; Vanhaesebroeck B; Khwaja A
Oncogene; 2006 Oct; 25(50):6648-59. PubMed ID: 16702948
[TBL] [Abstract][Full Text] [Related]
10. Cloning, expression, purification, and characterization of the human Class Ia phosphoinositide 3-kinase isoforms.
Meier TI; Cook JA; Thomas JE; Radding JA; Horn C; Lingaraj T; Smith MC
Protein Expr Purif; 2004 Jun; 35(2):218-24. PubMed ID: 15135396
[TBL] [Abstract][Full Text] [Related]
11. Class IA Phosphatidylinositol 3-Kinase Isoform p110α Mediates Vascular Remodeling.
Vantler M; Jesus J; Leppänen O; Scherner M; Berghausen EM; Mustafov L; Chen X; Kramer T; Zierden M; Gerhardt M; Ten Freyhaus H; Blaschke F; Sterner-Kock A; Baldus S; Zhao JJ; Rosenkranz S
Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1434-44. PubMed ID: 25908763
[TBL] [Abstract][Full Text] [Related]
12. A specific function for phosphatidylinositol 3-kinase alpha (p85alpha-p110alpha) in cell survival and for phosphatidylinositol 3-kinase beta (p85alpha-p110beta) in de novo DNA synthesis of human colon carcinoma cells.
Bénistant C; Chapuis H; Roche S
Oncogene; 2000 Oct; 19(44):5083-90. PubMed ID: 11042696
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of class II phosphoinositide 3-kinase alpha expression below a critical threshold induces apoptotic cell death.
Elis W; Triantafellow E; Wolters NM; Sian KR; Caponigro G; Borawski J; Gaither LA; Murphy LO; Finan PM; Mackeigan JP
Mol Cancer Res; 2008 Apr; 6(4):614-23. PubMed ID: 18403640
[TBL] [Abstract][Full Text] [Related]
14. RNA interference-mediated depletion of phosphoinositide 3-kinase activates forkhead box class O transcription factors and induces cell cycle arrest and apoptosis in breast carcinoma cells.
Reagan-Shaw S; Ahmad N
Cancer Res; 2006 Jan; 66(2):1062-9. PubMed ID: 16424042
[TBL] [Abstract][Full Text] [Related]
15. Distinct roles of class IA PI3K isoforms in primary and immortalised macrophages.
Papakonstanti EA; Zwaenepoel O; Bilancio A; Burns E; Nock GE; Houseman B; Shokat K; Ridley AJ; Vanhaesebroeck B
J Cell Sci; 2008 Dec; 121(Pt 24):4124-33. PubMed ID: 19033389
[TBL] [Abstract][Full Text] [Related]
16. TrkA overexpression enhances growth and metastasis of breast cancer cells.
Lagadec C; Meignan S; Adriaenssens E; Foveau B; Vanhecke E; Romon R; Toillon RA; Oxombre B; Hondermarck H; Le Bourhis X
Oncogene; 2009 May; 28(18):1960-70. PubMed ID: 19330021
[TBL] [Abstract][Full Text] [Related]
17. RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas.
Fagiani E; Giardina G; Luzi L; Cesaroni M; Quarto M; Capra M; Germano G; Bono M; Capillo M; Pelicci P; Lanfrancone L
Cancer Res; 2007 Apr; 67(7):3064-73. PubMed ID: 17409413
[TBL] [Abstract][Full Text] [Related]
18. The catalytic phosphoinositol 3-kinase isoform p110δ is required for glioma cell migration and invasion.
Luk SK; Piekorz RP; Nürnberg B; Tony To SS
Eur J Cancer; 2012 Jan; 48(1):149-57. PubMed ID: 22079609
[TBL] [Abstract][Full Text] [Related]
19. Characterization of PI3K class IA isoforms with regulatory subunit p55alpha using a scintillation proximity assay.
Van Aller GS; Carson JD; Fernandes C; Lehr R; Sinnamon RH; Kirkpatrick RB; Tummino PJ; Luo L
Anal Biochem; 2008 Dec; 383(2):311-5. PubMed ID: 18814837
[TBL] [Abstract][Full Text] [Related]
20. NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations.
Serra V; Markman B; Scaltriti M; Eichhorn PJ; Valero V; Guzman M; Botero ML; Llonch E; Atzori F; Di Cosimo S; Maira M; Garcia-Echeverria C; Parra JL; Arribas J; Baselga J
Cancer Res; 2008 Oct; 68(19):8022-30. PubMed ID: 18829560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
